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RE: Low Adherence to Guidelines in Nonmuscle-invasive Disease 
van Rhijn BWG, Burger M 
 
Nat Rev Urol 2016;13:570–1 
 
Experts’ summary: 
The authors address the thorny issue of the lack of adherence to Clinical Practice Guidelines 
highlighting high-quality evidence based nonmuscle-invasive bladder cancer (NMIBC) guideline 
recommendations from the American Urological Association/Society of Urologic Oncology, and the 
European Association of Urology as exemplars [1]. In particular, they emphasise three strong 
practice recommendations underpinned by high-quality evidence: immediate intravesical installation 
of chemotherapy in patients with presumed low-risk or intermediate-risk NMIBC, the performance 
of a second transurethral resection for high-risk NMIBC, and the administration of adjuvant 
intravesical Bacillus Calmette–Guérin immunotherapy in high-risk NMIBC. Data from North America, 
Europe, and Australia are cited illustrating variability and general lack of adherence (ranging from 
0.5% to 65%) to these recommendations. 
Interestingly, they propose that if young urologists, even from the best institutions, are not trained 
within environments whereby strong evidence-based practice recommendations are adhered to, 
they are unlikely to implement such practices as they embark on their independent careers. The 
obvious risks are that patients are not receiving the best care, care is not standardised, and patient 
outcomes are likely to be compromised. The excellent parting conclusion from the authors is that 
the reasons for the lack of adherence need to be investigated in future research and additionally 
they propose some strategies: (1) national adoption of international guidelines, (2) attendance at 
guideline update courses, and (3) increasing social media traffic [1]. 
 
Experts’ comments: 
This is an excellent article drawing attention to the current and pressing issue of suboptimal 
guideline adherence in the face of high-quality evidence and strong recommendations. Discordant 
adherence is apparent in other urological areas such the overuse of androgen deprivation therapy 
for low-risk prostate cancers [2] and the decreasing use of androgen deprivation therapy with 
radiotherapy for intermediate- and high-risk prostate cancer [3]. 
Now that we know there are evidence-practice gaps, we must address them; fortunately there is a 
significant body of implementation research across conditions from which we can learn [4]. The 
European Association of Urology Guidelines Office’s increasingly transparent and robust ways of 
systematically reviewing the evidence, and linking the quality of evidence to the strength of 
recommendations is an important first step in the knowledge-to-action cycle [5]. Now we should 
turn attention to: who needs to do what, differently? Which barriers and enablers need to be 
addressed? Which intervention components could overcome the modifiable barriers and enhance 
the enablers? How can behaviour change be measured and understood [6]? 
Addressing evidence-practice gaps depends on individuals changing their clinical behaviours within 
complex systems [7]. Potential barriers to adherence include a lack of knowledge/awareness, 
scepticism about key recommendations or the credibility of the source, a lack of resources or skills to 
*Manuscript
perform the optimal treatments, organisational/group commitment to a particular course of action 
which may limit autonomy or sanction deviance, a lack of belief in the beneficial consequences of 
the recommendations, disincentives to performing the treatments—among many other social, 
psychological, organisational, and environmental factors [7,8]. If we are to understand the problems 
and effect desired behaviour change, a theory-informed approach is necessary. 
The urological community must all march to the same beat adhering to strong recommendations. At 
least we stand a chance of finding out sooner whether the treatment/care being provided is right for 
patients or not; and if not, we change together. With the current alternative, we can be sure that at 
any one time, a significant proportion of patients are probably receiving suboptimal care and in 
some cases, harmful care. 
 
Conflicts of interest: The authors have nothing to disclose. 
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